Candesartan as an Adjunctive Treatment for Bipolar Depression
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and tolerability of Candesartan when used in patients with
Bipolar Disorder, in addition to their medication treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston